These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 16182312

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Botulinum toxin treatment of lateral axial dystonia in Parkinsonism.
    Bonanni L, Thomas A, Varanese S, Scorrano V, Onofrj M.
    Mov Disord; 2007 Oct 31; 22(14):2097-103. PubMed ID: 17685467
    [Abstract] [Full Text] [Related]

  • 4. Reoperation for suboptimal outcomes after deep brain stimulation surgery.
    Ellis TM, Foote KD, Fernandez HH, Sudhyadhom A, Rodriguez RL, Zeilman P, Jacobson CE, Okun MS.
    Neurosurgery; 2008 Oct 31; 63(4):754-60; discussion 760-1. PubMed ID: 18981887
    [Abstract] [Full Text] [Related]

  • 5. Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy.
    Giannantoni A, Rossi A, Mearini E, Del Zingaro M, Porena M, Berardelli A.
    J Urol; 2009 Oct 31; 182(4):1453-7. PubMed ID: 19683298
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Botulinum toxin type A for drooling in Parkinson's disease: a double-blind, randomized, placebo-controlled study.
    Lagalla G, Millevolte M, Capecci M, Provinciali L, Ceravolo MG.
    Mov Disord; 2006 May 31; 21(5):704-7. PubMed ID: 16440332
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Postural reactions to soleus muscle vibration in Parkinson's disease: scaling deteriorates as disease progresses.
    Valkovic P, Krafczyk S, Bötzel K.
    Neurosci Lett; 2006 Jun 19; 401(1-2):92-6. PubMed ID: 16574321
    [Abstract] [Full Text] [Related]

  • 15. The physiological effects of pallidal deep brain stimulation in dystonia.
    Tisch S, Rothwell JC, Limousin P, Hariz MI, Corcos DM.
    IEEE Trans Neural Syst Rehabil Eng; 2007 Jun 19; 15(2):166-72. PubMed ID: 17601185
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Adult-onset primary focal foot dystonia.
    Singer C, Papapetropoulos S.
    Parkinsonism Relat Disord; 2006 Jan 19; 12(1):57-60. PubMed ID: 16154790
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Botulinum toxin injections do not improve freezing of gait in Parkinson disease.
    Wieler M, Camicioli R, Jones CA, Martin WR.
    Neurology; 2005 Aug 23; 65(4):626-8. PubMed ID: 16116132
    [Abstract] [Full Text] [Related]

  • 20. Botulinum toxin injections to one leg alleviate freezing of gait in a patient with Parkinson's disease.
    Giladi N, Honigman S.
    Mov Disord; 1997 Nov 23; 12(6):1085-6. PubMed ID: 9399243
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.